263 related articles for article (PubMed ID: 18971237)
1. Effect of latanoprost and timolol on the histopathology of the human conjunctiva.
Terai N; Schlötzer-Schrehardt U; Lampel J; Böhm AG; Rummelt C; Schmidt E; Pillunat LE
Br J Ophthalmol; 2009 Feb; 93(2):219-24. PubMed ID: 18971237
[TBL] [Abstract][Full Text] [Related]
2. Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva.
Mietz H; Schlötzer-Schrehardt U; Strassfeld C; Krieglstein GK
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):679-87. PubMed ID: 11222527
[TBL] [Abstract][Full Text] [Related]
3. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
[TBL] [Abstract][Full Text] [Related]
4. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
[TBL] [Abstract][Full Text] [Related]
5. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.
Pisella PJ; Debbasch C; Hamard P; Creuzot-Garcher C; Rat P; Brignole F; Baudouin C
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1360-8. PubMed ID: 15111589
[TBL] [Abstract][Full Text] [Related]
6. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea.
Lopilly Park HY; Kim JH; Lee KM; Park CK
Exp Eye Res; 2012 Jan; 94(1):13-21. PubMed ID: 22067128
[TBL] [Abstract][Full Text] [Related]
7. Effect of latanoprost on the expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase 1 on the ocular surface.
Honda N; Miyai T; Nejima R; Miyata K; Mimura T; Usui T; Aihara M; Araie M; Amano S
Arch Ophthalmol; 2010 Apr; 128(4):466-71. PubMed ID: 20385943
[TBL] [Abstract][Full Text] [Related]
8. Synthesis pattern of matrix metalloproteinases (MMPs) and inhibitors (TIMPs) in human explant organ cultures after treatment with latanoprost and dexamethasone.
el-Shabrawi Y; Eckhardt M; Berghold A; Faulborn J; Auboeck L; Mangge H; Ardjomand N
Eye (Lond); 2000 Jun; 14 ( Pt 3A)():375-83. PubMed ID: 11027004
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha in ocular mucous membrane pemphigoid and its effect on conjunctival fibroblasts.
Saw VP; Dart RJ; Galatowicz G; Daniels JT; Dart JK; Calder VL
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5310-7. PubMed ID: 19494201
[TBL] [Abstract][Full Text] [Related]
10. Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo.
Mietz H; Esser JM; Welsandt G; Kociok N; Hueber A; Joussen A; Esser P; Krieglstein GK
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5182-8. PubMed ID: 14638715
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical antiglaucoma application on conjunctival impression cytology specimens.
Hong S; Lee CS; Seo KY; Seong GJ; Hong YJ
Am J Ophthalmol; 2006 Jul; 142(1):185-6. PubMed ID: 16815281
[TBL] [Abstract][Full Text] [Related]
12. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
Nenciu A; Stefan C; Ardelean C
Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
[TBL] [Abstract][Full Text] [Related]
13. Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue.
Ito T; Ohguro H; Mamiya K; Ohguro I; Nakazawa M
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):823-30. PubMed ID: 16505013
[TBL] [Abstract][Full Text] [Related]
14. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
[TBL] [Abstract][Full Text] [Related]
16. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term.
Baudouin C; Hamard P; Liang H; Creuzot-Garcher C; Bensoussan L; Brignole F
Ophthalmology; 2004 Dec; 111(12):2186-92. PubMed ID: 15582072
[TBL] [Abstract][Full Text] [Related]
17. Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma.
Konstas AG; Koliakos GG; Karabatsas CH; Liakos P; Schlötzer-Schrehardt U; Georgiadis N; Ritch R
Exp Eye Res; 2006 Feb; 82(2):319-22. PubMed ID: 16115621
[TBL] [Abstract][Full Text] [Related]
18. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?
Séguier S; Gogly B; Bodineau A; Godeau G; Brousse N
J Periodontol; 2001 Oct; 72(10):1398-406. PubMed ID: 11699482
[TBL] [Abstract][Full Text] [Related]
19. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open angle glaucoma.
Rismanchian A; Eslami F; Moeini H; Attarzade H; Naderibeni A
Saudi Med J; 2008 Mar; 29(3):384-7. PubMed ID: 18327364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]